Here's an interesting regulatory gap worth noting. While most jurisdictions haven't formally approved these two substances for medical use, very few actually prohibit their sale outright. That creates a loophole—vendors can legally market them as "experimental chemicals" without running afoul of the law. The catch? They simply can't make any health or medical claims. It's a classic gray market scenario: technically legal, yet obviously skirting the spirit of regulation.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
7 Likes
Reward
7
5
Repost
Share
Comment
0/400
StrawberryIce
· 6h ago
The gray area is always the most profitable, and regulation is just that weak...
View OriginalReply0
SleepTrader
· 6h ago
Playing in the gray area skillfully, always finding loopholes in the law.
View OriginalReply0
0xOverleveraged
· 6h ago
This set of tactics in the gray area really slowed down regulation. To put it simply, it's about exploiting loopholes, but there's really no way to say you're illegal.
View OriginalReply0
SchrodingerAirdrop
· 6h ago
The gray area tactics are really brilliant; they look legitimate but are actually just exploiting loopholes.
View OriginalReply0
BTCRetirementFund
· 7h ago
The gray area is operated this way, and regulation can never keep up with the market speed...
Here's an interesting regulatory gap worth noting. While most jurisdictions haven't formally approved these two substances for medical use, very few actually prohibit their sale outright. That creates a loophole—vendors can legally market them as "experimental chemicals" without running afoul of the law. The catch? They simply can't make any health or medical claims. It's a classic gray market scenario: technically legal, yet obviously skirting the spirit of regulation.